Joseph Burnett
CEO, President at ClearPoint Neuro, Inc. (CLPT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 20,000116,842 held (−15%) | $19.38 | $388K | -45.9% |
| Jun 22SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 60,000116,842 held (−34%) | $17.79 | $1.1M | -41.1% |
| Jun 22SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 1,843191,388 held (−1%) | $17.94 | $33K | -41.6% |
| Feb 26SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 19,951193,231 held (−9%) | $15.17 | $303K | -30.9% |
| Jan 27SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 2,943214,116 held (−1%) | $15.57 | $46K | -32.7% |
| Jan 13SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 20,00011,565 held (−63%) | $16.12 | $322K | -35.0% |
| Oct 14SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 17,583225,939 held (−7%) | $26.51 | $466K | -60.5% |
| Oct 14SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 6,599219,340 held (−3%) | $27.64 | $182K | -62.1% |
| Oct 14SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 1,981217,359 held (−1%) | $28.64 | $57K | -63.4% |
| Oct 14SEC | CLPTClearPoint Neuro, Inc. | Sell Plan | 300217,059 held (−0%) | $29.21 | $9K | -64.1% |
- Sell
CEO, President Joseph Burnett sold $388K of CLPT at $19.38 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joseph Burnett sold $1.1M of CLPT at $17.79 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joseph Burnett sold $33K of CLPT at $17.94 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joseph Burnett sold $303K of CLPT at $15.17 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joseph Burnett sold $46K of CLPT at $15.57 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joseph Burnett sold $322K of CLPT at $16.12 — cuts the stake by 63%; pre-scheduled 10b5-1 plan sale.